Publication Details

Pubmed29207594
Title: Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit.
Year: 2017
DOI: https://doi.org/10.18632/oncotarget.21544
First Author: Cao
Experimental setup: affinity chromatography technology (Biogrid)
pull down (Biogrid)
Throughput: Low Throughput (Biogrid)

Interactions

3 interactions
InteractorPartnerSourcesLink
RL11_HUMANRL22_HUMANBioGRIDdetails
RL22_HUMANRL5_HUMANBioGRIDdetails
MDM2_HUMANRL22_HUMANBioGRIDdetails